Morgan Stanley downgrades NortonLifeLock, sees 'limited catalysts' for the cybersecurity company

Kacper Pempel | REUTERS

A regulatory probe in the United Kingdom into NortonLifeLock's $8.6 billion deal with Avast and higher inflation costs are casting uncertainty over the company's stock, according to Morgan Stanley.

More In Street Calls

CNBC ProNeedham downgrades Analog Devices to hold, sees start of larger slowdown in semiconductors
CNBC ProWedbush downgrades Bed Bath & Beyond on Ryan Cohen's stock sale plan, predicts 80% tumble
CNBC ProMoffettNathanson downgrades Verizon to underperform as wireless landscape gets tougher